Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the year in 2025. Ozempic isn’t the only drug that mimics the natural GLP-1 ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...

New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...

US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that may mimic GLP-1 drugs for years after ...

Stephen has degrees in science (Physics major) and arts (English Literature and the History and Philosophy of Science), as well as a Graduate Diploma in Science Communication. Stephen has degrees in ...

Stopping Ozempic or Mounjaro can lead to weight regain for some people. Here’s what research shows about the “rebound effect” ...

In December 2025, the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight loss drug Wegovy, the first FDA-approved daily oral GLP-1 ...

From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to the rise of GLP-1 users The number of US adults taking GLP-1 drugs surged in ...

Real Housewives star Heather Gay shares why 30-pound weight loss with GLP-1 is a ‘miracle’ - The reality star started using ...

The desire for smaller portions and fewer junk foods is affecting what the food industry is selling us.